Melatonin

Related Topics:
Melatonin

Melatonin, 5-methoxy-N-acetyl tryptamine, is a hormone found in all living creatures from algae ^* to humans, at levels that vary in a diurnal cycle. In higher animals melatonin is produced by pinealocytes in the pineal gland (located in the brain) and also by the retina and GI tract. It is naturally synthesized from the amino acid tryptophan (derived from serotonin) by the enzyme 5-hydroxyindole-O-methyltransferase.

Many biological effects of melatonin are produced through activation of melatonin receptors, others are due to its role as a pervasive and extremely powerful antioxidant with a particular role in the protection of nuclear and mitochondrial DNA [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11462772&query_hl=47&itool=pubmed_DocSum. Melatonin is also synthesized by various plants, such as rice, and ingested melatonin has been shown to be capable of reaching and binding to melatonin binding sites in the brains of mammals.

Production of melatonin by the pineal gland is under the influence of the suprachiasmatic nucleus of the hypothalamus (SCN) which receives information from the retina about the daily pattern of light and darkness. This signal forms part of the system that regulates the circadian cycle, but it is the SCN that controls the daily cycle in most components of the paracrine and endocrine systems ^*^* rather than the melatonin signal (as was once postulated). Melatonin produced in the pineal gland acts as an endocrine hormone since it is released into the blood, whereas melatonin produced by the retina and the gastrointestinal (GI) tract acts as a paracrine hormone.

Role in the biological clock

Nobel Prize laureate Julius Axelrod performed many of the seminal experiments that elucidated the role of melatonin and the pineal gland in regulating sleep-wake cycles (circadian rhythms). Normally, production of melatonin by the pineal gland is inhibited by light and permitted by darkness. Until recent history, humans in temperate climates were exposed to up to eighteen hours of darkness in the winter. In the modern world, artificial lighting typically reduces this to eight hours or less per day all year round. Even low light levels inhibit melatonin production to some extent, but over-illumination can create significant reduction in melatonin production. Reduced melatonin production has been proposed as a likely factor in the significantly higher cancer rates in night workers and the effect of modern lighting practice on endogenous melatonin has been proposed as a contributory factor to the larger overall incidence of some cancers in the developed world [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15325001&query_hl=30&itool=pubmed_DocSum. As inadequate as blood concentrations may be in brightly-lit environments, some scientists now believe that people's overnight output of melatonin can be further jeopardized each time they interrupt their sleep and turn on a bright light (suggesting that the lower brightness level of a nightlight would be safer) . Others suppose that such short exposures do no harm.

Role as an antioxidant

Although the primary site of melatonin's action is via the melatonin receptors melatonin is a powerful antioxidant that can easily cross cell membranes and the blood-brain barrier redox cycling, the ability of a molecule to undergo reduction and oxidation repeatedly. Redox cycling may allow other antioxidants (such as vitamin C) to act as pro-oxidants, counterintuitively promoting free radical formation. Melatonin, once oxidized, cannot be reduced to its former state because it forms several stable end-products upon reacting with free radicals. Therefore, it has been referred to as a terminal (or suicidal) antioxidant. In animal models, melatonin has been demonstrated to prevent the damage to DNA by some carcinogens, stopping the mechanism by which they cause cancer. [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11239965&query_hl=46&itool=pubmed_docsum" target="_blank" >^*

The antioxidant activity of melatonin may reduce damage caused by some types of Parkinson's disease, may play a role in preventing cardiac arrhythmia and may increase longevity; it has been shown to increase the average life span of mice by 20% in some studies.

Role in immune system

The body of research is overwhelmingly supportive of the claim that melatonin boosts the immune system thereby helping to fight many diseases [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12596522&query_hl=74&itool=pubmed_DocSum.

Melatonin is an immunoregulator that enhances T cell production somewhat. When taken in conjunction with calcium, it is a very potent immunostimulator of the T cell response. Due to these immunoregulatory effects, it is used as an adjuvant in many clinical protocols; conversely, the increased immune system activity may aggravate autoimmune disorders.

Medical applications

Melatonin appears to have some use against insomnia, jet lag, and other types of misalignments in circadian rhythms. It has been studied for the treatment of cancer, immune disorders, cardiovascular diseases, depression, seasonal affective disorder (SAD), and sexual dysfunction. A study by Alfred J. Lewy and other researchers at OHSU found that it may ameliorate SAD and circadian misalignment, but as of 2006 it is known to affect the timing of endogenous melatonin production, raising the risk that it can exacerbate both clinical depression and SAD. Basic research indicates that melatonin may play a significant role in modulating the effects of drugs of abuse such as cocaine [http://www.nature.com/npp/journal/v28/n12/abs/1300254a.html.

Melatonin receptors appear to be important in mechanisms of learning and memory^*, and melatonin can alter electrophysiological processes associated with memory, such as long-term potentiation (LTP). Melatonin has been shown to prevent the hyperphosphorylation of the tau protein. Hyperphosphorylation of tau protein can result in the formation of neurofibrillary tangles, a pathological feature seen in Alzheimer's disease). Thus, melatonin may be effective for treating Alzheimer's Disease. These same neurofibrillary tangles can be found in the hypothalamus in patients with Alzheimer's, adversely affecting their body's production of melatonin. Those Alzheimer's patients with this specific affliction often show heightened afternoon agitation, called "sundowning," which has been shown in many studies to be effectively treated with melatonin supplements in the evening.

Recent research has concluded that melatonin supplementation in perimenopausal women produces a highly significant improvement in thyroid function and gonadotropin levels, as well as restoring fertility and menstruation and preventing the depression associated with the menopause ^*.

Several clinical studies indicate that supplementation with melatonin is an effective preventative treatment for migraine sufferers. ^* ^*

There may be other, far-reaching therapeutic uses for melatonin, such as in the treatment of various forms of cancer, HIV, and other viral diseases.

Use as a dietary supplement

The primary motivation for the use of melatonin as a supplement is as a natural aid to better sleep, with other incidental benefits to health and well-being due to its role as an antioxidant and its stimulation of the immune system and several components of the endocrine system.

Victor Herbert, M.D., J.D. Mt. Sinai School of Medicine cites studies from Massachusetts Institute of Technology that say melatonin pills sold as supplements contain three to 10 times the amount needed to produce the desirable physiologic nocturnal blood melatonin level for enhancement of nighttime rest. Dosages are designed to raise melatonin levels for several hours to enhance quality of sleep, but some studies suggest that smaller doses are just as effective at improving sleep quality ^*.

A number of studies indicate melatonin supplementation helps to reduce the age-related decline in hormone production from the thyroid and pituitary glands, among others, with animal models suggesting these effects are associated with an overall enhancement of health.

Melatonin is involved in the regulation of body weight, and may be helpful in treating obesity (especially when combined with calcium).

Melatonin is a hormone that is found in all forms of life on earth. In humans, it is produced by the pineal gland, a gland about the size of a pea, that is located in the center of the brain. The secretion of melatonin occurs during the night as a response to darkness, peaks in the middle of the night, and gradually falls during the second half of the night. The synthesis and release of melatonin is inhibited by light. For this reason melatonin has been called "the hormone of darkness." See for example http://www.superhormones.com/dev/faq.php?faqcategoryid=111&lang=eng.

Safety

Melatonin is practically nontoxic and exhibits almost no toxic side effects. However, melatonin taken in combination with monoamine oxidase inhibitors (MAOIs) can lead to overdose because MAOIs inhibit the breakdown of melatonin by the body. Exogenous melatonin normally does not affect the endogenous melatonin profile in the short or medium-term, merely advancing the phase of endogenous melatonin production in time. In individuals with auto-immune disorders, there is concern that melatonin supplementation may exacerbate symptoms due to stimulation of the immune system ^*.

Melatonin causes somnolence, and therefore should not be taken within five hours before driving, operating machinery, etc. As melatonin is almost always taken at the end of the waking day, this is generally not an issue.

Individuals who experience orthostatic intolerance, a cardiovascular condition that results in reduced blood pressure and blood flow to the brain when a person stands, may experience a worsening of symptoms when taking melatonins supplements, a study at Penn State College of Medicine's Milton S. Hershey Medical Center suggests. Melatonin can exacerbate the symptoms by reducing nerve activity in those who experience the condition, the study found. ^*

As a natural substance with a virtual absence of problematic side effects, with health benefits to users without illnesses, melatonin has been classified as a dietary supplement and made freely available in the USA, but in the EU over the counter sale without prescription is not yet officially permitted.

Role in zoology

Many animals use the variation in duration and quantity of melatonin production in each day as a seasonal clock In seasonal breeders which do not have long gestation periods, and which mate during longer daylight hours, the melatonin signal controls the seasonal variation in their sexual physiology, and similar physiological effects can be induced by exogenous melatonin in animals including mynah birds ^*. Melatonin can suppress libido by inhibiting secretion of luteinizing hormone (LH) and follicle stimulating hormone (FSH) from the anterior pituitary gland, especially in mammals that have a breeding season when daylight hours are long.

Melatonin is also related to the mechanism by which some amphibians and reptiles change the color of their skin.^*^*

External links

Melatonin at Medline plus
Melatonin by Ben Best
Exposure to bright light and melatonin production Science, January 16, 1987

References

Boutin JA, Audinot V, Ferry G, Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol Sci. 2005 Aug;26(8):412-9. PMID 15992934
Hattori A, Migitaka H, Iigo M, Itoh M, Yamamoto K, Ohtani-Kaneko R, Hara M, Suzuki T, Reiter RJ. Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem Mol Biol Int. 1995 Mar;35(3):627-34. PMID 7773197
Uz T, Arslan AD, Kurtuncu M, Imbesi M, Akhisaroglu M, Dwivedi Y, Pandey GN, Manev H. The regional and cellular expression profile of the melatonin receptor MT1 in the central dopaminergic system. Brain Res Mol Brain Res. 2005 May 20;136(1-2):45-53. PMID 15893586
Lee YA, Hyun KJ, Tokura H. The effects of skin pressure by clothing on circadian rhythms of core temperature and salivary melatonin. Chronobiol Int. 2000 Nov;17(6):783-93. PMID 11128295
Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 1999 Apr;55(2):111-5. PMID 10335905
Tan DX, Manchester LC, Reiter RJ, Qi WB, Karbownik M, Calvo JR. Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept. 2000 May-Aug;9(3-4):137-59. PMID 10899700
Dean W, Morgenthaler J, Fowkes SW. Smart Drugs II: The Next Generation : New Drugs and Nutrients to Improve Your Memory and Increase Your Intelligence. (Smart Drug Series, V. 2) Smart Publications; 1993. ISBN 0962741876
Anisimov VN, Alimova IN, Baturin DA, Popovich IG, Zabezhinski MA, Rosenfeld SV, Manton KG, Semenchenko AV, Yashin AI. Dose-dependent effect of melatonin on life span and spontaneous tumor incidence in female SHR mice. Exp Gerontol. 2003 Apr;38(4):449-61. PMID 12670632
Harder B. Bright Lights, Big Cancer: Melatonin-depleted blood spurs tumor growth. Science News. 2006 Jan;(169-1):8-10.
Oaknin-Bendahan S, Anis Y, Nir I, Zisapel N. Effects of long-term administration of melatonin and a putative antagonist on the ageing rat. Neuroreport. 1995 Mar 27;6(5):785-8. PMID 7605949
Lewy AJ, Sack RL, Miller LS, Hoban TM. Antidepressant and circadian phase-shifting effects of light. Science. 1987 Jan 16;235(4786):352-4. PMID 3798117
Larson J, Jessen RE, Uz T, Arslan AD, Kurtuncu M, Imbesi M, Manev H. Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice. Neurosci Lett. 2006 Jan 23;393(1):23-6. PMID 16203090
Wang LM, Suthana NA, Chaudhury D, Weaver DR, Colwell CS. Melatonin inhibits hippocampal long-term potentiation. Eur J Neurosci. 2005 Nov;22(9):2231-7. PMID 16262661
Wang XC, Zhang J, Yu X, Han L, Zhou ZT, Zhang Y, Wang JZ. Prevention of isoproterenol-induced tau hyperphosphorylation by melatonin in the rat. Sheng Li Xue Bao. 2005 Feb 25;57(1):7-12. PMID 15719129
Maestroni GJ. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. J Physiol Biochem. 2004 Mar;60(1):61-72. PMID 15352385
Barrenetxe J, Delagrange P, Martinez JA. Physiological and metabolic functions of melatonin. Trends Pharmacol Sci. 2005 Aug;26(8):412-9. PMID 15992934
Volicer, L., Harper, D. G., Maning, B. C., Goldstein, R., & Satlin, A. (2001). Sundowning and circadian rhythms in Alzheimer's disease. American Journal of Psychiatry, 158^*, 704-711.

Gourt Home::Gourt :: Melatonin